Cargando…

TRPV1 Is a Potential Tumor Suppressor for Its Negative Association with Tumor Proliferation and Positive Association with Antitumor Immune Responses in Pan-Cancer

BACKGROUND: Although numerous studies have shown that the expression and activation of TRPV1 have an important role in cancer development, a comprehensive exploration of associations between TRPV1 expression and tumor proliferation, microenvironment, and clinical outcomes in pan-cancer remains insuf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Rongfang, Liu, Qian, Wang, Xiaosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596243/ https://www.ncbi.nlm.nih.gov/pubmed/36304985 http://dx.doi.org/10.1155/2022/6964550

Ejemplares similares

Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma
por: Liu, Qian, et al.
Publicado: (2021)

Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization
por: Zhang, Lijuan, et al.
Publicado: (2021)

Pan-cancer molecular analysis of the RB tumor suppressor pathway
por: Knudsen, Erik S., et al.
Publicado: (2020)

TRPV1 acts as a Tumor Suppressor and is associated with Immune Cell Infiltration in Clear Cell Renal Cell Carcinoma: evidence from integrated analysis
por: Zheng, Long, et al.
Publicado: (2020)

Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity
por: Grabovska, Yura, et al.
Publicado: (2020)

Clinical significance, tumor immune landscape and immunotherapy responses of ADAR in pan-cancer and its association with proliferation and metastasis of bladder cancer
por: Yu, Hao, et al.
Publicado: (2023)

Oncogene or tumor suppressor gene: An integrated pan-cancer analysis of NBPF1
por: Li, Lei, et al.
Publicado: (2022)

SUMOylation of Csk Negatively Modulates its Tumor Suppressor Function
por: Cui, Nan, et al.
Publicado: (2019)

TRPV4 channel activation selectively inhibits tumor endothelial cell proliferation
por: Thoppil, Roslin J., et al.
Publicado: (2015)

Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression
por: Liberati, Sonia, et al.
Publicado: (2014)

Roles of tumor suppressors in regulating tumor-associated inflammation
por: Yang, L, et al.
Publicado: (2014)

Pan-Cancer Analysis Reveals That E1A Binding Protein p300 Mutations Increase Genome Instability and Antitumor Immunity
por: Chen, Zuobing, et al.
Publicado: (2021)

CD206(+) tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity
por: Modak, Madhura, et al.
Publicado: (2022)

NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells
por: Nagai-Singer, Margaret A., et al.
Publicado: (2023)

A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment
por: Shao, Wei, et al.
Publicado: (2023)

The spliceosome pathway activity correlates with reduced anti-tumor immunity and immunotherapy response, and unfavorable clinical outcomes in pan-cancer
por: Chen, Zuobing, et al.
Publicado: (2021)

Tumor reductive therapies and antitumor immunity
por: Guo, Huiqin, et al.
Publicado: (2017)

Pan-cancer analysis of the FAM83 family and its association with prognosis and tumor microenvironment
por: Yuan, Shangkun, et al.
Publicado: (2022)

Identifying tumor immunity-associated molecular features in liver hepatocellular carcinoma by multi-omics analysis
por: Shen, Qianyun, et al.
Publicado: (2022)

Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling
por: Lu, Qiqi, et al.
Publicado: (2023)

Pan-Cancer Analysis of the TRP Family, Especially TRPV4 and TRPC4, and Its Expression Correlated with Prognosis, Tumor Microenvironment, and Treatment Sensitivity
por: Chen, Zhenghao, et al.
Publicado: (2023)

Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects
por: Veeramachaneni, Ratna, et al.
Publicado: (2021)

Identification of the Putative Tumor Suppressor Characteristics of FAM107A via Pan-Cancer Analysis
por: Ou, Dehua, et al.
Publicado: (2022)

Tumor immune microenvironment (TIME) to enhance antitumor immunity
por: Rajbhandary, Sajin, et al.
Publicado: (2023)

Tumor-Associated Macrophages as Target for Antitumor Therapy
por: Sawa-Wejksza, Katarzyna, et al.
Publicado: (2017)

Pan-cancer analysis reveals tumor-associated macrophage communication in the tumor microenvironment
por: Wang, Linbang, et al.
Publicado: (2021)

Pan-cancer Analysis of NEDD4L and Its Tumor Suppressor Effects in Clear Cell Renal Cell Carcinoma
por: Dong, Huiyue, et al.
Publicado: (2021)

Pan-Cancer Analysis Reveals Genomic and Clinical Characteristics of TRPV Channel-Related Genes
por: Wang, Xiaoxuan, et al.
Publicado: (2022)

Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study
por: Zhao, Min, et al.
Publicado: (2016)

Comprehensive analysis of PILRΑ’s association with the prognosis, tumor immune infiltration, and immunotherapy in pan-cancer
por: Li, Qiao, et al.
Publicado: (2023)

Antitumor activity of pan‐HER inhibitors in HER2‐positive gastric cancer
por: Yoshioka, Takahiro, et al.
Publicado: (2018)

Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
por: Tripathi, Brajendra K., et al.
Publicado: (2021)

Oncogenic and tumor suppressor function of MEIS and associated factors
por: GİRGİN, Birkan, et al.
Publicado: (2020)

Domains controlling cell polarity and proliferation in the Drosophila tumor suppressor Scribble
por: Zeitler, Jennifer, et al.
Publicado: (2004)

Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation
por: D’Souza, Amber M., et al.
Publicado: (2018)

Evaluation of the effects of meteorological factors on COVID-19 prevalence by the distributed lag nonlinear model
por: Ai, Hongjing, et al.
Publicado: (2022)

Immune Infiltration of MMP14 in Pan Cancer and Its Prognostic Effect on Tumors
por: Li, Minde, et al.
Publicado: (2021)

Differentiated tumor immune microenvironment of Epstein–Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy
por: Ma, Jing, et al.
Publicado: (2017)

Positive and negative functions of B lymphocytes in tumors
por: Shen, Meng, et al.
Publicado: (2016)

Tumor suppressor ARF: The new player of innate immunity
por: Través, Paqui G., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l6q5uo6t9bh1lm37kndu8hohma